Biofrontera Inc. (NASDAQ: BFRI)
$1.08
+0.0100 ( +0.94% ) 23.3K
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
Market Data
Open
$1.08
Previous close
$1.07
Volume
23.3K
Market cap
$5.55M
Day range
$1.08 - $1.13
52 week range
$0.61 - $12.99
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k/a | 8K-related | 14 | Apr 03, 2024 |
8-k | 8K-related | 15 | Mar 26, 2024 |
def | Proxies and info statements | 6 | Mar 21, 2024 |
8-k | 8K-related | 16 | Mar 15, 2024 |
10-k | Annual reports | 122 | Mar 15, 2024 |
pre | Proxies and info statements | 6 | Mar 08, 2024 |
8-k | 8K-related | 20 | Feb 23, 2024 |
8-k | 8K-related | 19 | Feb 20, 2024 |
8-k | 8K-related | 15 | Feb 13, 2024 |
8-k | 8K-related | 16 | Feb 05, 2024 |